Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Eller

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Mediators of Inflammation|September 9, 2017
Experimental Porcine <i>Toxoplasma gondii</i> Infection as a Representative Model for Human ToxoplasmosisJulia Nau, Silvia Kathrin Eller, Johannes Wenning, et al.
Wiener Klinische Wochenschrift|September 20, 2023
[Diagnosis and therapy of membranous nephropathy-2023]Marcus D Säemann, Balazs Odler, Martin Windpessl, et al.
Wiener Klinische Wochenschrift|June 12, 2026
[Consensus paper for the standardized laboratory diagnostics of chronic kidney disease (CKD) in the context of cardiovascular-renal-metabolic health (ÖGLMKC, ÖQUASTA, ÖGN) : Consensus paper of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), the Austrian Society for Quality Assurance and Standardization of Medical Diagnostic Examinations (ÖQUASTA), and the Austrian Society for Nephrology (ÖGN)]Kathrin Eller, Thomas Koller, Christoph Buchta, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Diabetes|September 14, 2011
Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathyKathrin Eller, Alexander Kirsch, Anna M Wolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.
Wiener Klinische Wochenschrift|September 20, 2023
[Diagnosis and treatment of Minimal Change Disease in adults-2023]Philipp Gauckler, Heinz Regele, Kathrin Eller, et al.
Endocrine Connections|March 3, 2023
Hospitalizations, emergency room visits and causes of death in 198 patients with permanent hypoparathyroidism: a retrospective Austrian study (2005-2022)Julia Herteux, Simon Johannes Geiger, Christina Starchl, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Myocardial infarction with non-obstructive coronary arteries in a patient double-seropositive for anti-glomerular basement membrane and anti-neutrophil cytoplasmic antibodies: A case reportMarcell Krall, Johannes Gollmer, Marion J Pollheimer, et al.
Plos One|July 18, 2013
Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritisKathrin Eller, Andrea Schroll, Miriam Banas, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Mediators of Inflammation|September 9, 2017
Experimental Porcine <i>Toxoplasma gondii</i> Infection as a Representative Model for Human ToxoplasmosisJulia Nau, Silvia Kathrin Eller, Johannes Wenning, et al.
Wiener Klinische Wochenschrift|September 20, 2023
[Diagnosis and therapy of membranous nephropathy-2023]Marcus D Säemann, Balazs Odler, Martin Windpessl, et al.
Wiener Klinische Wochenschrift|June 12, 2026
[Consensus paper for the standardized laboratory diagnostics of chronic kidney disease (CKD) in the context of cardiovascular-renal-metabolic health (ÖGLMKC, ÖQUASTA, ÖGN) : Consensus paper of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), the Austrian Society for Quality Assurance and Standardization of Medical Diagnostic Examinations (ÖQUASTA), and the Austrian Society for Nephrology (ÖGN)]Kathrin Eller, Thomas Koller, Christoph Buchta, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Diabetes|September 14, 2011
Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathyKathrin Eller, Alexander Kirsch, Anna M Wolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.
Wiener Klinische Wochenschrift|September 20, 2023
[Diagnosis and treatment of Minimal Change Disease in adults-2023]Philipp Gauckler, Heinz Regele, Kathrin Eller, et al.
Endocrine Connections|March 3, 2023
Hospitalizations, emergency room visits and causes of death in 198 patients with permanent hypoparathyroidism: a retrospective Austrian study (2005-2022)Julia Herteux, Simon Johannes Geiger, Christina Starchl, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Myocardial infarction with non-obstructive coronary arteries in a patient double-seropositive for anti-glomerular basement membrane and anti-neutrophil cytoplasmic antibodies: A case reportMarcell Krall, Johannes Gollmer, Marion J Pollheimer, et al.
Plos One|July 18, 2013
Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritisKathrin Eller, Andrea Schroll, Miriam Banas, et al.
Pageof 14